Company Filing History:
Years Active: 1999-2010
Title: The Innovations and Impact of Inventor Paul William Glue
Introduction
Paul William Glue is a renowned inventor based in Flemington, NJ, with a significant contribution to the field of pharmaceuticals. With an impressive portfolio of seven patents, Glue has focused his research and inventions on improving medical treatments, particularly in areas such as urinary incontinence and viral infections.
Latest Patents
Among his latest inventions, one patent addresses the "Use of neurokinin antagonists in the treatment of urinary incontinence." This invention relates to compounds with specific chemical configurations that are defined in the specification. These compounds are intended for use as pharmaceuticals, aiming to enhance the treatment options available for urinary incontinence.
Another notable patent from Glue is centered on "HCV combination therapy." This patent describes methods for treating patients suffering from chronic hepatitis C infections. It involves administering a combination of interferon-alfa and ribavirin in conjunction with an antioxidant to mitigate ribavirin-related hemolysis. This innovative approach highlights Glue's commitment to improving the efficacy of treatments for viral infections.
Career Highlights
Paul William Glue has had a distinguished career, contributing to significant advancements in the pharmaceutical industry. He worked with notable companies including Schering Corporation and Novartis AG, where he applied his expertise to develop groundbreaking medical solutions.
Collaborations
Throughout his career, Glue has collaborated with respected colleagues, including David L. Cutler and Melton B. Affrime. These partnerships have allowed for a fusion of ideas and expertise, enriching the development process of his innovations.
Conclusion
In summary, Paul William Glue stands out as an influential inventor whose work has had a considerable impact on the pharmaceutical field, particularly in treating urinary incontinence and chronic viral infections. With his impressive patent portfolio and collaborative efforts, Glue continues to push the boundaries of medical innovation, providing valuable contributions to healthcare.